Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00509678 · ClinicalTrials.gov registry record · Phase 1
Rituxan With or Without Methotrexate in Psoriatic Arthritis
A Phase 1 study, sponsored by Swedish Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT00509678 is a Phase 1 study that has completed, run by Swedish Medical Center. The registered enrollment target is 6 participants.
The verdict
NCT00509678, a Phase 1 study, has completed, sponsored by Swedish Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to help determine the effectiveness of rituxan (with or without methotrexate) in the treatment of psoriatic arthritis.
Interventions
- DRUG Rituximab
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2006-12 |
| Est. Completion | 2010-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00509678
The ClinicalTrials.gov registry entry for NCT00509678 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Swedish Medical Center, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Rituximab is the first listed.
NCT00509678 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00509678 about?
NCT00509678 is a clinical study titled "Rituxan With or Without Methotrexate in Psoriatic Arthritis". The purpose of this study is to help determine the effectiveness of rituxan (with or without methotrexate) in the treatment of psoriatic arthritis.
What is the current status of trial NCT00509678?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2006-12. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00509678?
The interventions under investigation include: Rituximab (DRUG).
Who is sponsoring clinical trial NCT00509678?
This trial is sponsored by Swedish Medical Center, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.